Intelligence Unit
Special Reports
Special Events
Subscribe
Sponsored
Departments
- Leadership
- Finance
- Technology
- Physicians
- Community Hospitals
- Health Plans
- Marketing
- Quality
- Nursing
- HR
Follow Us
Oral Cancer Drugs Deserve Parity
Oral cancer drugs account for 25% to 35% of the drugs in the cancer drug pipeline. But their high costs are causing some cancer patients to avoid them. It's time for health plans to treat these drugs like injectable cancer-fighting medications.